CSIMarket


Q Biomed inc   (QBIO)
Other Ticker:  
 
 

QBIO's Revenue Growth by Quarter and Year

Q Biomed Inc 's Revenue results by quarter and year




QBIO Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter November - 0.02 - -
III Quarter August 0.05 0.02 - -
II Quarter May 0.05 - - -
I Quarter February - - - -
FY   0.10 0.04 - -



QBIO Revenue third quarter 2021 Y/Y Growth Comment
Q Biomed inc achieved in the third quarter, above Company average Revenue surge of 128.38% year on year, to $ 0.05 millions.

Looking into third quarter results within Biotechnology & Pharmaceuticals industry 21 other companies have achieved higher Revenue growth. While Q Biomed Inc ' s Revenue doubling of 128.38% ranks overall at the positon no. 202 in the third quarter.




QBIO Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter November - - - -
III Quarter August 128.38 % - - -
II Quarter May - - - -
I Quarter February - - - -
FY   - - - -

Financial Statements
Q Biomed Inc 's third quarter 2021 Revenue $ 0.05 millions QBIO's Income Statement
Q Biomed Inc 's third quarter 2020 Revenue $ 0.02 millions Quarterly QBIO's Income Statement
New: More QBIO's historic Revenue Growth >>


QBIO Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter November - 0 % - -
III Quarter August -8.65 % - - -
II Quarter May - - - -
I Quarter February - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #22
Healthcare Sector #64
Overall #202

Revenue Y/Y Growth Statistics
High Average Low
204.5 % 20.9 % -100 %
(Aug 31 2021)   (Feb 28 2019)
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #22
Healthcare Sector #64
Overall #202
Revenue Y/Y Growth Statistics
High Average Low
204.5 % 20.9 % -100 %
(Aug 31 2021)   (Feb 28 2019)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Q Biomed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
613.33 % 70.43 % -100 %
(Nov 30 2017)  


QBIO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Q Biomed Inc realized drop in Revenue sequentially by -8.65% to $ 0.05 millions, from $ 0.05 millions released in the previous quarter.

Within Biotechnology & Pharmaceuticals industry 64 other companies have achieved higher Revenue quarter on quarter growth. While Q Biomed Inc 's Revenue growth quarter on quarter, overall rank is 2243.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #65
Healthcare Sector #326
Overall #2243
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #65
Healthcare Sector #326
Overall #2243
Revenue Q/Q Growth Statistics
High Average Low
613.33 % 70.43 % -100 %
(Nov 30 2017)  


QBIO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Q Biomed Inc realized drop in Revenue from the second quarter by -8.65% to $ 0.05 millions, from $ 0.05 millions released in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 64 other companies have achieved higher Revenue quarter on quarter growth. While Q Biomed Inc 's Revenue growth quarter on quarter, overall rank is 2243.


Q Biomed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Aug 31 2021)
12 Months Ending
(May 31 2021)
12 Months Ending
(Feb 28 2021)
12 Months Ending
(Aug 31 2020)
12 Months Ending
(May 31 2020)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Aug 31 2021 period, Q Biomed Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Q Biomed inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Aug 31 2021 period, Q Biomed Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Q Biomed inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QBIO's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for QBIO's Competitors
Revenue Growth for Q Biomed Inc 's Suppliers
Revenue Growth for QBIO's Customers

You may also want to know
QBIO's Annual Growth Rates QBIO's Profitability Ratios QBIO's Asset Turnover Ratio QBIO's Dividend Growth
QBIO's Roe QBIO's Valuation Ratios QBIO's Financial Strength Ratios QBIO's Dividend Payout Ratio
QBIO's Roa QBIO's Inventory Turnover Ratio QBIO's Growth Rates QBIO's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Aug 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Aug 31 2021
Q Biomed inc 204.50%$ 204.500 millions
Nurix Therapeutics Inc 150.97%$ 150.967 millions
Bespoke Extracts Inc 119.83%$ 119.826 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VYST's Profile

Stock Price

VYST's Financials

Business Description

Fundamentals

Charts & Quotes

VYST's News

Suppliers

VYST's Competitors

Customers & Markets

Economic Indicators

VYST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071